- Home
- About mondoBIOTECH
- Investors
- Corporate Fact Sheet
- Company Presentation
- All Reports
- Corporate Governance
- Share Information
- Financial Calendar
- Shareholders’ Meeting
- Investor Relation Contact
- Media Releases
- Business Partners
- Pipeline
- Community
- Careers
- Contact Us
Search
| Investors - Media Releases | ||
| Stay Informed | ||
|
2004
| ||
| July 28, 2004 |
| mondoBIOTECH and Bachem sign agreement for Aviptadil project |
| mondoBIOTECH Holding SA and Bachem AG (SWX: BANB) today announced a collaboration agreement for production and supply of mondoBIOTECH ´s lead compound Aviptadil. mondoBIOTECH is entering phase II clinical trial to treat pulmonary arterial hypertension and plans to bring Aviptadil to the market in 2007. |
